Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands

MK Bakker,a J Jentink,b F Vroom,b PB Van Den Berg,b HEK De Walle,a LTW De Jong-Van Den Bergb a EUROCAT Northern Netherlands, Department of Medical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands bDepartment of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, University Institute for Drug Exploration (GUIDE), University of Groningen, Groningen, The Netherlands Correspondence: Prof Dr LTW De Jong-Van Den Berg, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, University Institute for Drug Exploration (GUIDE), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. Email l.t.w.de.jong-van.den.berg@rug.nl

[1]  Marsha A Raebel,et al.  Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data , 2005, Pharmacoepidemiology and drug safety.

[2]  S. Hernández-Díaz,et al.  Use of over-the-counter medications during pregnancy. , 2005, American journal of obstetrics and gynecology.

[3]  G. Koren,et al.  Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. , 2005, American journal of obstetrics and gynecology.

[4]  J. Hasford,et al.  Drug prescription in pregnancy: analysis of a large statutory sickness fund population , 2004, European Journal of Clinical Pharmacology.

[5]  Robert L Davis,et al.  Prescription drug use in pregnancy. , 2004, American journal of obstetrics and gynecology.

[6]  H. Tobi,et al.  Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. , 2004, Journal of clinical epidemiology.

[7]  Hilde Tobi,et al.  Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[8]  H. Tobi,et al.  How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information , 2004, Pharmacoepidemiology and drug safety.

[9]  P. Neuvonen,et al.  Prescription drugs during pregnancy and lactation—a Finnish register-based study , 2003, European Journal of Clinical Pharmacology.

[10]  R. Davis,et al.  Outcomes of prenatal antidepressant exposure. , 2002, The American journal of psychiatry.

[11]  P. Burney,et al.  Paracetamol use in pregnancy and wheezing in early childhood , 2002, Thorax.

[12]  P. Villiger,et al.  Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. , 2002, Transplant immunology.

[13]  J. Urquhart,et al.  Automated Pharmacy Record Linkage in The Netherlands , 2002 .

[14]  L. de Jong-van den Berg,et al.  Do Pregnant Women Report Use of Dispensed Medications? , 2001, Epidemiology.

[15]  M. Lapeyre-Mestre,et al.  Prescription of drugs during pregnancy in France , 2000, The Lancet.

[16]  G. Baglìo,et al.  Drug use in pregnancy among Italian women , 2000, European Journal of Clinical Pharmacology.

[17]  S. Wiebe.  Managing women with epilepsy , 2000, BMJ : British Medical Journal.

[18]  L. de Jong-van den Berg,et al.  Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. , 1999, Acta obstetricia et gynecologica Scandinavica.

[19]  G. Zielhuis,et al.  Medication during low-risk pregnancy. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[20]  L. Jong‐van den Berg,et al.  Investigating drug use in pregnancy , 1991, Pharmaceutisch Weekblad.